CHARLES E BUGG Insider Trading $BCRX BIOCRYST PHARMACEUTICALS INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for CHARLES E BUGG.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of CHARLES E BUGG. CHARLES E BUGG is CEO in BIOCRYST PHARMACEUTICALS INC ($BCRX) and CEO, Chairman in BIOCRYST PHARMACEUTICALS INC ($BCRX).
CHARLES E BUGG in BIOCRYST PHARMACEUTICALS INC
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of CHARLES E BUGG: CEO, Chairman, CEO
Holdings: 57,557 shares
Current Value: $326,348
Latest Transaction: Sep 27 2005
$BCRX Market Capitalization: $427.06M
$BCRX Previous Close: $5.67
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of CHARLES E BUGG in BIOCRYST PHARMACEUTICALS INC
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 27 2005 | BCRX | BIOCRYST PHARMACEU ... | BUGG CHARLES E | CEO, Chairman | Option Exercise | M | 8.88 | 100,000 | 887,500 | 0 | |
| Sep 27 2005 | BCRX | BIOCRYST PHARMACEU ... | BUGG CHARLES E | CEO, Chairman | Sell | S | 10.25 | 100 | 1,025 | 57,557 | 57.7 K to 57.6 K (-0.17 %) |
| Sep 27 2005 | BCRX | BIOCRYST PHARMACEU ... | BUGG CHARLES E | CEO, Chairman | Sell | S | 10.13 | 900 | 9,117 | 57,657 | 58.6 K to 57.7 K (-1.54 %) |
| Sep 27 2005 | BCRX | BIOCRYST PHARMACEU ... | BUGG CHARLES E | CEO, Chairman | Sell | S | 10.12 | 250 | 2,530 | 58,557 | 58.8 K to 58.6 K (-0.43 %) |
| Sep 27 2005 | BCRX | BIOCRYST PHARMACEU ... | BUGG CHARLES E | CEO, Chairman | Sell | S | 10.11 | 100 | 1,011 | 58,807 | 58.9 K to 58.8 K (-0.17 %) |
| Sep 27 2005 | BCRX | BIOCRYST PHARMACEU ... | BUGG CHARLES E | CEO, Chairman | Sell | S | 10.10 | 200 | 2,020 | 58,907 | 59.1 K to 58.9 K (-0.34 %) |
| Sep 27 2005 | BCRX | BIOCRYST PHARMACEU ... | BUGG CHARLES E | CEO, Chairman | Sell | S | 10.06 | 1,200 | 12,072 | 59,107 | 60.3 K to 59.1 K (-1.99 %) |
| Sep 27 2005 | BCRX | BIOCRYST PHARMACEU ... | BUGG CHARLES E | CEO, Chairman | Sell | S | 10.05 | 100 | 1,005 | 60,307 | 60.4 K to 60.3 K (-0.17 %) |
| Sep 27 2005 | BCRX | BIOCRYST PHARMACEU ... | BUGG CHARLES E | CEO, Chairman | Sell | S | 10.04 | 600 | 6,024 | 60,407 | 61 K to 60.4 K (-0.98 %) |
| Sep 27 2005 | BCRX | BIOCRYST PHARMACEU ... | BUGG CHARLES E | CEO, Chairman | Sell | S | 10.03 | 500 | 5,015 | 61,007 | 61.5 K to 61 K (-0.81 %) |
| Sep 27 2005 | BCRX | BIOCRYST PHARMACEU ... | BUGG CHARLES E | CEO, Chairman | Sell | S | 10.02 | 100 | 1,002 | 61,507 | 61.6 K to 61.5 K (-0.16 %) |
| Sep 27 2005 | BCRX | BIOCRYST PHARMACEU ... | BUGG CHARLES E | CEO, Chairman | Sell | S | 10.00 | 90,950 | 909,500 | 61,607 | 152.6 K to 61.6 K (-59.62 %) |
| Sep 27 2005 | BCRX | BIOCRYST PHARMACEU ... | BUGG CHARLES E | CEO, Chairman | Buy | M | 8.88 | 100,000 | 887,500 | 152,557 | 52.6 K to 152.6 K (+190.27 %) |
| May 14 2004 | BCRX | BIOCRYST PHARMACEU ... | BUGG CHARLES E | CEO | Option Exercise | A | 8.83 | 52,613 | 464,573 | 611,514 | |
| Apr 29 2004 | BCRX | BIOCRYST PHARMACEU ... | BUGG CHARLES E | CEO | Option Exercise | M | 4.63 | 100,000 | 462,500 | 558,901 | |
| Apr 29 2004 | BCRX | BIOCRYST PHARMACEU ... | BUGG CHARLES E | CEO | Sell | S | 9.55 | 7,500 | 71,657 | 52,557 | 60.1 K to 52.6 K (-12.49 %) |
| Apr 29 2004 | BCRX | BIOCRYST PHARMACEU ... | BUGG CHARLES E | CEO | Sell | S | 9.55 | 10,000 | 95,500 | 60,057 | 70.1 K to 60.1 K (-14.27 %) |
| Apr 29 2004 | BCRX | BIOCRYST PHARMACEU ... | BUGG CHARLES E | CEO | Sell | S | 9.50 | 67,500 | 641,250 | 70,057 | 137.6 K to 70.1 K (-49.07 %) |
| Apr 29 2004 | BCRX | BIOCRYST PHARMACEU ... | BUGG CHARLES E | CEO | Grant | A | 4.63 | 100,000 | 462,500 | 137,557 | 37.6 K to 137.6 K (+266.26 %) |
Page: 1